Home page
Scientific Program Highlights
19 Mar
- Nick Panay
Origin and impact of VMS: the enigma unravelled!
- Petra Stute
Hot flushes: Insight into daily challenges and coping strategies
- Katrine Schaudig
Hot flushes: individualized treatment
19 Mar
- Andrea Genazzani
Opening Remarks
- Minister of Health of the Republic of Latvia Hon. Hosams Abu Meri
Opening of the Congress
- David Serfaty
In memoriam of Professor Clara Pélissier-Langbort
19 Mar
- Nick Panay
Updated ESHRE POI guidelines: a global collaboration
19 Mar
- Isabel Pérez Fernández
P2. Enhanced myometrial vascularity after termination of pregnancy.
- Anastasia Bothou
P3. Is sentinel lymph node biopsy (SLNB) safe for breast cancer during pregnancy (PrBC)?
- Isabel Pérez Fernández
P4. Metaplastic breast cancer: a difficult and unexpected diagnosis
- Filomena Silveira
P5. Invasive ductal carcinoma of the breast in a male patient: a case report
- Tanja Boehnke
P6. Ease of intrauterine device insertion - Does Body Mass Index make a difference?
- Jelisaveta Džigurski
P7. Comprehensive Analysis of Hormonal Contraceptive Use in the Estonian Biobank
- Cristina Guazzelli
P8. Contraception methods use in adolescents with mental disorder
- Cristina Guazzelli
P9. Analysis of the quality of the videos about the contraceptive vaginal ring released on the social network Tiktok
- Cristina Guazzelli
P10. Adolescents' contraceptive choices in the immediate postpartum period: a cohort study
- Lucie Raskin
P11. Are natural estrogens used in contraception at lower risk of venous thromboembolism than synthetic ones? A systematic literature review and meta-analysis
- Lucie Raskin
P12. Reduced Risk of Venous Thromboembolism with Natural Estrogen-Based COCs Compared to Ethinylestradiol Pills: Evaluation of Venous Thromboembolism Adverse Events Reported in FAERS for COCs
- Angelos Daniilidis
P13. Endometriosis-Associated Infertility: Mechanisms and Treatment Strategies
- Charlotte Hütig
P14. Phenotypes of Endometriosis and Anti-Müllerian Hormone (AMH) – Is there a correlation?
- Alexandra Irma Gabriela Bausic
P15. Gut Microbiota in Endometriosis - can it be used as a screening method?
- Angelos Daniilidis
P16. What is the role of Molecular Biomarkers at endometriosis related infertility? A narrative review of literature.
- Ball Elizabeth
P17. How to run an online knowledge exchange type focus group for new service developments and grant applications
- Larissa Meirelles
P18. Adenomyosis: The impact of using the Levonorgestrel-Releasing Intrauterine System (LNG-IUS)
- Oleksandr Shevchuk
P19. Endometrial and placental parallels of morphological and immunohistochemical changes in women with hyperproliferative diseases of the uterus
- Oleh Revenko
P20. Characteristics of the illnes and psycho-emotional condition of women with uterine leiomyoma and adenomyosis affected by war
- Mohamad Moafak Hariri
P21. The clinical challenge of Cotyledonoid dissecting leiomyoma (CDL) with adenomyosis.
- Bojana Petrovic
P22. The discovery of the COL4A5 gene mutation responsible for Alport syndrome in a fetus with polyhydramnios
- Yan Wang
P23. Practice of oncology nurses-led model on the genetic risk assessment and management of ovarian cancer
- Gina Vich
P24. A high concentration of niosomal hyaluronic acid moisturizing gel for vaginal dryness and dyspareunia. a clinical trial final results
- Marlene Hager
P26. Changes in Prolactin and Insulin Resistance in PCOS Patients Undergoing Metformin Treatment: A Retrospective Study
- Taisiia Krysenko
P27. Stress and Displacement and PCOS Psychological Symptoms
- Hisayo Okayama
P28. Characterization of PMS questionnaire responses in women based on cerebral blood flow during cognitive tasks
- Tetiana Osaulenko
P29. Examining the Impacts of Ukrainian War on Menstrual Disorders Among Childbearing Women: A Scoping Review and a Case Study
- Kateryna Plaksiieva
P30. Reproductive System Disorders in Female Military Personnel Arising After the Onset of the Full-Scale Invasion of Ukraine
- Nino Sharashenidze
P31. Thyroid pathology during pregnancy in georgian population
- Milina Tančić-Gajić
P32. Infertility in Polycystic Ovary Syndrome: What Is the True Underlying Cause?
- Eriko Terasawa
P33. Characterization of heart rate and R-R interval obtained by smartwatch during follicular, luteal, and menstrual phases to track the menstrual cycle.
- Tetiana Tutchenko
P34. Impact of liver function on the clinical presentation of PCOS
- Anda Florentina Pavel
P35. Multiple Primary Malignant Neoplasms; ovarian, endometrial and breast cancer: a case report
- Emma Boretti
P36. Risk of neoplasm with fezolinetant: summary of clinical trials and regulatory documents
- Joseph Carroll
P37. Effect of Doxorubicin and Mulberry Extract on Reactive Species Generation and Nuclear Rupture in Ovarian Cancer Cells
- Chi-Chang Chang
P38. Prediction of Risk Factors for Endometrial Second Primary Cancer Using AI Models
- Jone Gondra
P39. Assessment of myometrial invasion in endometrial cancer
- Filomena Silveira
P40. Carcinomatous Lymphangitis in Breast Cancer Progression
- Amyntas Giotas
P41. Small bowel obstruction masking a perforated ovarian cyst.
- Roberta Maria Arseni
P42. Minilaparotomy Myomectomy in Symptomatic Uterine Fibroids
- Isadora Kozlowski
P43. Leiomyomatosis associated with reed syndrome - a case report
- Aras Valančius
P44. Feasibility of minimal invasive surgery in a morbidly obese patient with large myomatous uterus
- Aras Valančius
P45. The role of laparoscopy in challenging clinical situation dealing with huge myomatous uterus
- Stefanos Zervoudis
P46. “Sandwich” technique for the Management of Chronic Hemorrhagic Cervicitis
- Marina Nunes Machado
P47. Guillain Barré syndrome and pregnancy: a case report
- Bojana Petrovic
P48. The evaluation of treatment protocols used for managing preterm premature rupture of membranes
- Yoshino Saito
P49. Association of urinary sodium-potassium ratio with self-reported dietary habits of pregnant women in early pregnancy.
- Olena Yaroshchuk
P50. Placenta previa Outpatient management instead of planned hospitalization. Optimization of the management algorithm (original study)
- Ljiljana Zdelar Stojanovic
P51. Monitoring antibodies during pregnancy – Do we pay enough attention to RhD-positive mothers?
- Cecilia Caetano
P52. Sleep disturbance in menopausal women with vasomotor symptoms: findings from two Phase 3 studies
- Nick Panay
P53. Effect of elinzanetant for the treatment of vasomotor symptoms associated with menopause: pooled data from two Phase 3 studies
- Celine Bouchard
P54. Trial in Progress: HIGHLIGHT 1 - A randomized, placebo-controlled, double-blind, phase 3 clinical study to investigate the efficacy and safety of fezolinetant for treatment of moderate-to-severe vasomotor symptoms (hot flashes) in women with stage 0 to 3 hormone receptor-positive breast cancer who are receiving adjuvant endocrine therapy
- Cecilia Caetano
P55. EMPOWER: Evaluating Menopausal symPtom treatment Options and WomEns’ pReferences
- Angelos Daniilidis
P56. A case report of surgical management of postmenopausal endometriosis of the rectum with atypia
- Nina Davidova
P57. Effectiveness of Vaginal Pessaries in the Conservative Management of Pelvic Organs Prolapse
- Carina Dinkel-Keuthage
P58. Does sleep disturbance have an impact on depression and anxiety in perimenopausal and postmenopausal women? A Europe-based survey
- Gaisma Gurska
P59. Vasomotor symptoms after surgical Menopause: a prospective cohort study from riga east clinical university hospital
- Sae Kyung Joo
P60. Impact of Menopause on Liver Fibrosis Progression in Metabolic Dysfunction-Associated Steatotic Liver Disease
- Rossella E Nappi
P61. Effect of elinzanetant for the treatment of vasomotor symptoms associated with menopause across BMI and smoking history subgroups: pooled data from two Phase 3 studies
- Rossella E Nappi
P62. Effect of elinzanetant for the treatment of vasomotor symptoms associated with menopause across race and ethnicity subgroups: pooled data from two Phase 3 studies
- Lili Stefanova Vateva
P63. Menopausal Hormone Therapy (MHT) for women with underlying disease – a scoping review
- Gina Vich
P64. A multicomponent food supplement alleviates climacteric symptoms improving quality of life of menopausal women: A descriptive clinical study
- Nevton Pereira Costa
P65. Metabolic Syndrome: Impacts on the health of climacteric women
- Guldjahan Babadjanova
P66. Hemorrhoids in pregnant women – a cause of reduced quality of life for women
- Ismini Kountouri
P67. A case of a spontaneously resolved persistent pregnancy of unknown location.
- Karolina Misevičiūtė
P68. Spontaneous Regression of Primary Fetal Hydrothorax
- Anastasia Bothou
P69. A Current Analysis of Common Dietary Patterns During Pregnancy and Breastfeeding: Trends, Advantages, and Difficulties
- Elena Casolati
P70. Gynecologists’ attitude and approach for the management of Nausea and Vomiting in Pregnancy in Italy: the PURITY FLEX survey
- Lilia Galindo Ortega
P71. codigo mater
- Amyntas Giotas
P72. Ruptured Hepatic Hemangioma in the Third Trimester of Pregnancy: A Rare Case Report
- Isadora Kozlowski
P73. Maternal nearmiss - mortality, morbidity and the impact of this global problem
- Meilė Minkauskienė
P74. The Impact of Preterm Premature Rupture of Membranes on Chorioamnionitis Rates and Maternal and Newborn Health
- Mitsuki Nojima
P75. Stress felt by mothers in the Neonatal Intensive Care Unit
- Marina Nunes Machado
P76. Epidemiological Profile of Perinatal Mortality in a Tertiary Hospital
- Oleksandr Shevchuk
P77. Features of hemostasis and key genetic markers in pregnant women with hyperproliferative uterine diseases
- Stefanos Zervoudis
P78. Rusty Pipe Syndrome during Breastfeeding Our Experience
- Jelena Andrejeva
P79. The role of an interdisciplinary approach to the treatment of patients with premature ovarian insufficiency
- Nigar Kamilova
P80. Assessment of hormonal profile in polycystic ovary syndrome in adolescent girls
- Ilir Tasha
P81. Fetoplacental mosaicism and non-invasive procedure testing (case study)
- Kiyoko Naito
P82. Creation of an animated video for a digital health system to instruct pelvic floor muscle training for women with urinary incontinence
- Štefica Findri-Guštek
P83. Development And Testing of New Herbal Ointment for the Treatment of Stress Urinary Incontinence
- Sanae Ninomiya
P84. Seasonal changes in lower urinary tract symptoms in Japanese women: an online-based survey
- Jone Gondra
P85. Surgery for hypertrophy of the labia minora of the vulva: an 8-year retrospective study
- Marie Didembourg
P86. Evaluation of neutralizing antibody titers against SARS-CoV-2 JN.1 Omicron subvariant during pregnancy - A case series study
- Julie Escola
P87. Diversity of infectious vaginitis: results of a multicenter observational study of Neomycin-Nystatin-Neomycin-Polymyxin B combination as empirical therapy in routine clinical practice
- Nataliia Kosei
P88. Features of vaginal microbiocenosis in military women and women involved in war with complaints of abnormal vaginal discharge
- Daniela Tasha
P89. Incidence of mycoplasma hominis, ureaplasma urealyticum and pregnancy outcome
- Daniela Tasha
P90. Chlamydia Trachomatis in women with tubo – ovarian infertility and chronic pelvic pain.
- Ana Filipa Ferreira
P91. Reproductive outcomes in a population of women with infertility and congenital uterine anomalies
- Olha Trokhymovych
P92. The state of the vaginal microbiome in women with hyperproliferative diseases of the uterus under the influence of long-term stress in conditions of military aggression
20 Mar
- Tommaso Simoncini
Pelvic organs prolapse
20 Mar
- Nick Panay
New perspectives for management of menopausal symptoms - NK antagonists
- Rossella Nappi
Incidence and impact of menopausal symptoms on quality of life and long-term health
- Tommaso Simoncini
Current management options for menopausal symptoms
20 Mar
- Joaquim Calaf Alsina
Menopause and vaginal atrophy: challenges, impact, and current solutions
- Chiara Stefani
A new frontier in VVA treatment: science and benefits of HCC
- Elisabetta Garavaglia
From theory to practice: clinical insights and real-world applications
- Joaquim Calaf Alsina
Empowering women’s health through innovation
-
Q&A
20 Mar
- Terhi Piltonen
Panelist
- Angelica Lindén Hirschberg
Panelist
- Jonathan Douxfils
Panelist
20 Mar
- Pedro Barri
Importance of the endometrial preparation for FET for the risk of preeclampsia
- Mauro Cozzolino
The importance of the LPS in endometriosis and adenomyosis
- Michael Von Wolff
Indication for or against fertility preservation
20 Mar
- Rimantas Gricius
The effect of endometrial scratching on biomarkers of endometrial receptivity in IVF cycle
- Raminta Baušytė
Perspective in endometrial – factor induced infertility: stem cell therapy
- Johannes Ott
Oocyte donation in women with Turner syndrome: what are the risks
- Joseph Schenker
Gonadal failure: synthetic gametes future therapeutic modalities
20 Mar
- Olga Plisko
The Current Diagnostic Criteria for Uterine Fibroids
- Dace Matule
A review of the current medical treatment options for uterine fibroids
- Ronalds Mačuks
Surgical Treatment of Uterine fibroids: Advantages and risks
20 Mar
- Ludwig Kiesel
Novel aspects on the pathomechanisms of adenomyosis and endometriosis
- Stefano Luisi
Medical treatment for adenomyosis and endometriosis
- Stefano Angioni
Surgery for deep endometriosis when and how
- Tevfik Yoldemir
ART outcomes in women with endometriosis
20 Mar
- Andrzej Milewicz
Obesity and menopause
- Tommaso Simoncini
A matter of hormones: how to address endometrial cancer risk in obese patients
20 Mar
- Mark Brincat
Tailored HRT using bodyidential hormones: improving the results and lowering the risks
- Nathalie Chabbert-Buffet
Endometriosis in the peri/post menopause
- Angelica Lindén Hirschberg
Breast and endometrial safety of natural progesterone compared to progestogen in menopausal hormone therapy
- Andrea Genazzani
Androgens supplementation for a better menopause hormone therapy
20 Mar
- John Stevenson
The impact of HRT on cardiovascular risk
- Jean-Yves Reginster
An overview of 40 years of progress in the management of osteoporosis: where do we come from, where are we and where are we going to?
- Eef Hogervorst
The national guidelines on MHT for prevention of dementia stroke
- Franco Borruto
New strategies for oncological prophylaxis in women: the microbiota
20 Mar
- Žana Bumbulienė
Sertoli-Leydig cell tumor in adolescent girl
- Laima Maleckienė
Large uterine leiomyoma in a 15-year-old girl
- Kristina Jarienė
Herlyn-Werner-Wunderlich syndrome: case reports
20 Mar
- Pavel Calda
First trimester ultrasound diagnostics of PAS
- Frédéric Chantraine
How to make the prenatal assessment for PAS at best?
- Natalija Vedmedovska
Vasa praevia: where are we now?
- Wolfgang Holzgreve
Update on Non-Invasive Prenatal Testing (NIPT)
20 Mar
- Ana Teresa Almeida Santos
Social fertility preservation: preventing or promoting the postponement of motherhood?
- Ana Filipa Ferreira
Social fertility preservation: preventing or promoting the postponement of motherhood?
20 Mar
- Jana Žodžika
Cervical cancer screening: quo vadis?
- Andrea Giannini
From molecular classification to clinical practice in endometrial cancer: what's new?
- Vilius Rudaitis
Do we really need robotics in oncogynecology?
- Stefanos Zervoudis
Updates in breast cancer oncoplastic surgery
20 Mar
- Błażej Męczekalski
Neurokinin B and Kisspeptin in gynecological endocrinology
- Alessandro Genazzani
Integrative approach to Functional Hypothalamic Amenorrhea
- Tetiana Tatarchuk
The influence of prolonged stress on the clinical course metabolic risks of PCOS
- Katarzyna Paczkowska
Novel approach to early detection and treatment of metabolic disturbances in polycystic ovary syndrome
20 Mar
- Kateryna Plaksiieva
PCOS: where are we now and where do we go next?
- Tetiana Tutchenko
Current epidemiology of PCOS and emerging approaches to phenotyping
- Natalia Pedachenko
PCOS in clinical portraits
- Elina Manzhalii-Christian
Impact of liver function on the clinical presentation of PCOS
20 Mar
- Florin Isopescu
Contributions to the study of menarcheal age in Bacau county Romania
- Petra Stute
Reaching out to patients: real-world evidence underscores lack of awareness and diagnosis for primary dysmenorrhea but not premenstrual syndrome (PMS)
- Haluk Kelestimur
The Effects of Asprosin on Metabolic and Reproductive Hormonal Factors in the Rats
- Elisabed Pkhaladze
Impact of Weight on Hormonal and Metabolic Patterns in Classic Polycystic Ovary Syndrome Across Age Groups
- Tetiana Tutchenko
A Case Series of Secondary Amenorrhea in Lean PCOS Women. To the question of Functional Hypothalamic Amenorrhea Development in PCOS
- Joaquim Calaf Alsina
The add-back concept revisited
- Olha Trokhymovych
Menstrual cycle disorders and hormonal homeostasis in women with adenomyosis and uterine leiomyoma who were exposed to factors of military aggression.
- Joaquim Calaf Alsina
A sequential approach to fibroid management with oral GnRH antagonists.
- Geet Sarodey
Endometrial cancer in Hormone replacement therapy users with postmenopausal bleeding: Retrospective cohort study
- Mohamed Abdelrahman
Intrauterine Balloon Tamponade for management of life threatening menorrhagia.
20 Mar
- Beatrise Dinsberga
Retrospective study of birth outcome and birth complications in patients with increased BMI in a Riga Hospital Labor department, 2023.
- Beate Vitola
Retrospective study of birth outcome and complications in patients with induced labour in a single hospital in Riga 2023
- Zane Krastiņa
Cesarean Section rate in Robson groups as quality measure of evidence based obstetrical care in Latvia and single reference level hospital in Latvia in six years period.
- Gabija Žilinskienė
Pregnancy and Labour in a Primary Early-Onset Dystonia Patient Treated with Deep Brain Stimulation of Globus Pallidus Internus: A Case Report and Literature Review
20 Mar
- Antoine Watrelot
Simplified technique of trans laparoscopic cerclage for late miscarriage: a 120 cases continuous series
- Agate Kalcenaua
Enhancing the Monitoring and Management of Gestational Diabetes through Digital Health Solutions
- Anita Yadav
Enhancing maternal healthcare: utilization and barriers of Anganwadi services among pregnant and lactating women in rural India
- Ebru Yücel
The Impact of Turkish Bath Habits on Pregnancy Outcomes: A Retrospective Analysis of 214 Pregnant Women
- Menbere Abadii
Exploring Digital mHealth Tools in Preconception Care for Individuals at Risk for Feto-Maternal Complications: An Integrative Review
- Danielė Berulė
The Impact of Maternal Weight on Pregnancy Complications among Primiparous Women: A Retrospective Study from a Tertiary Care Center
- Ilir Tasha
Confined placental mosaicism and maternal mosaicism can be underlying biological causes of discordant results of Non – invasive procedure testing during screening of pregnancy for chromosomal abnormalities.
- Eliona Demaliaj
Preeclampsia and Neonatal Outcomes in Albania: A Retrospective Analysis
- Paulina Stalgyte
Maternal mirror syndrome with fetal hydrops due to parvovirus infection
- Daniela Tasha
UREAPLASMA UREALYTICUM AND MYCOPLASMA HOMINIS INFECTION AMONG PREGNANT WOMEN
- Tomasz Milewicz
Intestinal microbiota differs in gestational diabetes women.
- Elina Priede
Gestational Diabetes Mellitus (GDM) Care: Uncovering Gaps in Screening and Postpartum Follow-Up
20 Mar
- Roxana Schwab
Mental Health in Adversity: Psychological challenges in women with endometriosis during the COVID-19 pandemic
- Mohamed Abdelrahman
Management of Bronchial endometriosis
- Cristina Maria Iacob
Extrapelvic endometriosis. Minimally invasive management of inguinal endometriosis-video presentation
- Vera Kovacevic
Laser treatman of endometrioma:Comparison two different sources of energy to achieve haemostasis after laparoscpic surgery of endometrioma / a diode laser (DWLS) vs bipolar electrocoagulation.
- Pawel Basta
Linzagolix effectively reduces endometriosis-associated pain versus placebo: Results from the phase 3 EDELWEISS-3 trial
- Tomasz Paszkowski
Linzagolix rapidly reduces Heavy Menstrual Bleeding in patients with uterine fibroids: A pooled analysis of the PRIMROSE 1 and 2 trials
- Pawel Basta
EDELWEISS-6: A long-term extension study of linzagolix for the management of endometriosis-associated pain
- Tomasz Paszkowski
Linzagolix for the treatment of uterine fibroids: Efficacy and safety results at one-year and up to 6 months following cessation of treatment
- Jarbas Magalhaes
ADENOMYOSIS: Uterine volume, bleeding patterns, and contraceptive outcomes in users of the levonorgestrel-releasing intrauterine system: a real-life cohort study with a five-year follow-up.
21 Mar
- Pedro Barri
Update on Preimplantation Genetic Diagnosis. From PGT-A to PGT-M and to non-invasive testing
21 Mar
- Manuela Farris
The new generation Z gender identity and sexuality
- Camil Castelo-Branco
Tips & tricks for talking about sexuality
- Rossella Nappi
Reproductive milestones and women’s sexuality
- Marie Abel
Asking your patients about sex: opening Pandora's box
- Svetlana Vujovic
Successful sexuality in premature ovarian insufficiency: new approach
21 Mar
- Andrew Horne
The past, present and future of medical treatment of endometriosis
- Mariona Rius
How do we use GnRH-antagonist combination therapy in everyday clinical practice
21 Mar
- Pedro Melo
Mechanisms, prediction and prevention of preeclampsia
- Roland Devlieger
Lifestyle factors affecting pregnancy outcome
- Angharad Care
Current evidence in the prevention of preterm birth
21 Mar
- Panagiotis Drakopoulos
The role of androgens as pre-treatment in IVF
- Raoul Orvieto
Triggering final follicular maturation- hCG, GnRH-agonist or both, when and to whom?
- Filippo Ubaldi
Dual Stimulation, to whom and when
21 Mar
- Andrea Genazzani
Estrogen decline and its effect on hot flushes, mood and vaginal atrophy - The science, the DT56A and our ability to treat women
21 Mar
- Kai Haldre
Impact of rapid socio-economic changes on sexual and reproductive health in Estonia in the end of the 20th and beginning of the 21st century
- Jaana Below
Implementation of sexuality education and youth counselling services in Estonia
- Olga Khrustaleva
Spectrum of simulation trainings in obstetrics and gynaecology in West Tallinn Central Hospital
21 Mar
- Ali Kubba
Contraceptive compliance: do not blame the women!
- Ineta Vasaraudze
The various applications of hormonal intrauterine contraception in modern times
- David Serfaty
New vision on bacterial vaginosis: prevalence in IUD users
- Kristina Gemzell-Danielsson
An update on emergency contraception
21 Mar
- Alfred Mueck
Membrane-bound steroid receptors as markers to predict breast cancer risk during HRT
- Xiangyan Ruan
Development of new tumour markers to predict the prognosis of breast cancer patients
21 Mar
- Birutė Žilaitienė
The great debate: pharmaceuticals or food supplements?
- Mihaela Grigore
The great debate: pharmaceuticals or food supplements?
- Mihaela Grigore
The HPV dilemma: myths, facts, and controversies
- Belén López Cavanillas
Paloma II: data unveiled - Insights from the latest study
- Belén López Cavanillas
Case studies uncovered: lessons from the frontlines
-
Q&A
- Anna Mallafré Vilar
Beyond metformin: Myo-Inositol to D-Chiro-Inositol ratios for fertility support. Does a golden ratio exist?
- Anna Mallafré Vilar
Clinical case spotlight: learning from experience
-
Q&A
21 Mar
- Archil Khomasuridze
Reproductology as the Independent Medical Discipline. The Georgian Experience
21 Mar
- Charles Sultan
Abnormal uterine bleeding during adolescence
- Natalia Pedachenko
Abnormal uterine bleeding due to ovulatory dysfunction (AUB-O)
- Ali Kubba
Management of abnormal uterine bleeding in complex patients
21 Mar
- Angelos Daniilidis
Tubal surgery in the era of ART
- Michelle Nisolle
Anticipation and management of surgical complications of endometriosis
- Tommaso Simoncini
Reinventing vaginal surgery: the vNOTES revolution
- Tomi Mikkola
Tapes or bulking for stress urinary incontinence?
21 Mar
- Peter Greenhouse
Specific positional deep dyspareunia pattern aids clinical diagnosis of endometriosis
- Stefan Ückert
Prevalence of Symptoms of Sexual Dysfunction in a Cohort of Young Female Students
- Andreas Bannowsky
What are the expectations of the female partners of the patients on penile rehabilitation programs after nerve-sparing prostatectomy?
- Gina Vich
Adjuvant treatment with a non-hormonal centella Asiatica, hyaluronic acid and prebiotic-based vaginal gel in women with recurrent vaginal dysbiosis: case series
- Angelos Daniilidis
10-step-approach of laparoscopic pectopexy combined with supracervical hysterectomy.
21 Mar
- Terhi Piltonen
Is PCOS still “a mystery syndrome”, what is the awareness of the condition?
- Bart Fauser
Ongoing challenges in diagnostic criteria for PCOS, why is it relevant?
- Lāsma Līdaka
Adolescents with PCOS: important aspects of mental health
- Basil Tarlatzis
Treatment of infertility in women with PCOS: an evidence-based approach
21 Mar
- Romualdo Sciorio
Optimize euman embryo culture to improve single blastocyst transfer in assisted reproductive treatments
21 Mar
- Valérie Bernard
Non hormonal treatments of vasomotor symptoms
- Christine Rousset-Jablonski
Genito-urinary syndrome of menopause management in breast cancer survivors
- Nathalie Chabbert-Buffet
Breast arterial calcifications as a cardiovascular risk?
21 Mar
- Rossella Nappi
Qualitative assessment of the impact of VMS on the lives of women with vasomotor symptoms associated with menopause who are not suitable candidates for hormone therapy
- Carina Dinkel-Keuthage
Associations between Vasomotor Symptoms, Sleep Disturbances, and Frequent Mood Changes in Menopausal Women: Analysis of Data from the Study of Women's Health Across the Nation
- Lydia Marié-Scemama
How the gynecologist is involved with the prevention of the disease coming in perimenopausal and menopausal women
- Paul CM Piette
Clinical meaningful evidence to Monitor and optimize transdermal MHT
- Celine Bouchard
Estetrol (E4) Provides Complete Relief from Vasomotor Symptoms in One-Third of Participants in the E4COMFORT I Phase 3 Clinical Trial
- Gina Opolskiene
The changes in endometrial thickness in women who use sequential menopausal hormonal therapy (MHT)
- Christian Battipaglia
Effects of MYO-inositol (MYO) and Banaba extract standardized to 1% corosolic acid (BNB) supplementation on HOMA-IR and HIE (Hepatic Insulin Extraction) in Overweight/Obese Postmenopausal Women
- Geet Sarodey
Menopause and the role of regular exercise – a survey of women aged 40–65
- Katrina Elina Berzina
Latvian Cheeses an Important Source of Calcium for the Prevention and Treatment for Premenopausal and Menopausal Woman
- Štefica Findri-Guštek
Acupuncture and herbal medicinal products in the treatment of perimenopausal and menopausal symptoms in women
21 Mar
- Anna Mallafré Vilar
Supplementation with 3.6:1 Myo-Inositol/D-Chiro-Inositol, Antioxidants and Probiotics to Improve Oocyte Quality and Increase Pregnancy Chances in Women with History of ART Failures without PCOS
- Anna Mallafré Vilar
Treatment with a patented 3.6:1 Myo-Inositol/D-Chiro-Inositol, Antioxidants and Probiotics to Increase Pregnancy Chances in Women with Advanced Maternal Age and Low Ovarian Reserve
- Jan Greguš
Antinatalism and Intended Infertility
- Attila Jakab
Prevalence and impact of female endocrine disorders in assisted reproduction
- Violeta Fodina
Follicular fluid oxidative-reductive potential – the marker for assisted reproductive treatment outcomes.
- Filipe Alexandre Rodrigues Nobrega
Is the Number of Follicles on the Day of hCG Trigger Related to the Pregnancy Rate in Intrauterine Insemination?
- Nina Davidova
The value of Progesterone Induced Blocking Factor in the prognosis of Early Pregnancy Loss
- Natalia Kosei
A NEW IMMUNOHISTOCHEMICAL MARKER IN THE CHRONIC ENDOMETRITIS DIAGNOSIS
- Nino Museridze
The triad Stem cell, Exosomes and PRP therapy Male and Female Fertility prof. Nino Museridze MD PhD
The Congress will be held in Riga, a surprising destination with its colorful city center rich in history and art. The old town itself has a protected status, featuring buildings dating back to the city’s founding in 1201, along with an unparalleled art nouveau neighborhood.
TRANSLATIONS
Congress sessions will be translated into several languages to accommodate our diverse audience.
Enjoy seamless real-time translation during presentations, ensuring you don’t miss any critical information.
ACCOMMODATIONS
The 16 Congress of the European Society of Gynecology has chosen Revolugo as official travel agency partner.
Check our solutions in guaranteed hotels at very convenient prices.
GENERAL INFO
Get ready for the congress! Click below for all the crucial info and contact details you’ll need.
Don’t miss out—prepare to make the most of your experience!
Scientific and organizing committee of the congress

Andrea Genazzani
Rome

Camil Castelo Branco
Barcelona

Mark Brincat
Malta

Zana Bumbuliene
Vilnius

Mairi Kaha
Tallinn

Andrzej Milewicz
Wrocław

Michelle Nisolle
Liège

David Serfaty
Paris

Tommaso Simoncini
Pisa

Ineta Vasaraudze
Riga